215 related articles for article (PubMed ID: 8691435)
21. Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid.
Beard RL; Colon DF; Song TK; Davies PJ; Kochhar DM; Chandraratna RA
J Med Chem; 1996 Aug; 39(18):3556-63. PubMed ID: 8784454
[TBL] [Abstract][Full Text] [Related]
22. Determinants of retinoid X receptor transcriptional antagonism.
Cavasotto CN; Liu G; James SY; Hobbs PD; Peterson VJ; Bhattacharya AA; Kolluri SK; Zhang XK; Leid M; Abagyan R; Liddington RC; Dawson MI
J Med Chem; 2004 Aug; 47(18):4360-72. PubMed ID: 15317450
[TBL] [Abstract][Full Text] [Related]
23. Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity.
Dawson MI; Hobbs PD; Peterson VJ; Leid M; Lange CW; Feng KC; Chen Gq ; Gu J; Li H; Kolluri SK; Zhang Xk ; Zhang Y; Fontana JA
Cancer Res; 2001 Jun; 61(12):4723-30. PubMed ID: 11406543
[TBL] [Abstract][Full Text] [Related]
24. Antiproliferative activity and apoptosis induced by retinoic acid receptor-gamma selectively binding retinoids in neuroblastoma.
Meister B; Fink FM; Hittmair A; Marth C; Widschwendter M
Anticancer Res; 1998; 18(3A):1777-86. PubMed ID: 9673404
[TBL] [Abstract][Full Text] [Related]
25. Identification of highly potent retinoic acid receptor alpha-selective antagonists.
Teng M; Duong TT; Johnson AT; Klein ES; Wang L; Khalifa B; Chandraratna RA
J Med Chem; 1997 Aug; 40(16):2445-51. PubMed ID: 9258350
[TBL] [Abstract][Full Text] [Related]
26. Induction of apoptosis in MCF-7 breast carcinoma cell line by RAR and RXR selective retinoids.
Toma S; Isnardi L; Riccardi L; Bollag W
Anticancer Res; 1998; 18(2A):935-42. PubMed ID: 9615744
[TBL] [Abstract][Full Text] [Related]
27. Activity of retinoic acid receptor-gamma selectively binding retinoids alone and in combination with interferon-gamma in breast cancer cell lines.
Widschwendter M; Daxenbichler G; Culig Z; Michel S; Zeimet AG; Mörtl MG; Widschwendter A; Marth C
Int J Cancer; 1997 May; 71(3):497-504. PubMed ID: 9139890
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: dependence on AP-1 activation, but not on retinoid response element activation.
Wan H; Dawson MI; Hong WK; Lotan R
Oncogene; 1997 Oct; 15(17):2109-18. PubMed ID: 9366527
[TBL] [Abstract][Full Text] [Related]
29. C3 halogen and c8'' substituents on stilbene arotinoids modulate retinoic Acid receptor subtype function.
Alvarez S; Khanwalkar H; Alvarez R; Erb C; Martínez C; Rodríguez-Barrios F; Germain P; Gronemeyer H; de Lera AR
ChemMedChem; 2009 Oct; 4(10):1630-40. PubMed ID: 19670208
[TBL] [Abstract][Full Text] [Related]
30. Molecular basis for designing selective modulators of retinoic acid receptor transcriptional activities.
Lefebvre P
Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):153-64. PubMed ID: 12476796
[TBL] [Abstract][Full Text] [Related]
31. Syntheses and structure-activity relationships of novel retinoid X receptor agonists.
Hibi S; Kikuchi K; Yoshimura H; Nagai M; Tai K; Hida T
J Med Chem; 1998 Aug; 41(17):3245-52. PubMed ID: 9703470
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D3- and retinoic acid-induced monocytic differentiation: interactions between the endogenous vitamin D3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells.
Botling J; Oberg F; Törmä H; Tuohimaa P; Bläuer M; Nilsson K
Cell Growth Differ; 1996 Sep; 7(9):1239-49. PubMed ID: 8877104
[TBL] [Abstract][Full Text] [Related]
33. Pyrazine arotinoids with inverse agonist activities on the retinoid and rexinoid receptors.
García J; Khanwalkar H; Pereira R; Erb C; Voegel JJ; Collette P; Mauvais P; Bourguet W; Gronemeyer H; de Lera AR
Chembiochem; 2009 May; 10(7):1252-9. PubMed ID: 19343742
[TBL] [Abstract][Full Text] [Related]
34. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation.
Chen JY; Penco S; Ostrowski J; Balaguer P; Pons M; Starrett JE; Reczek P; Chambon P; Gronemeyer H
EMBO J; 1995 Mar; 14(6):1187-97. PubMed ID: 7720709
[TBL] [Abstract][Full Text] [Related]
35. Disila-analogues of the synthetic retinoids EC23 and TTNN: synthesis, structure and biological evaluation.
Gluyas JB; Burschka C; Dörrich S; Vallet J; Gronemeyer H; Tacke R
Org Biomol Chem; 2012 Sep; 10(34):6914-29. PubMed ID: 22814352
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional activation of a model reporter system by retinoids and retinoic acid receptor isoforms.
Huggenvik JI; Sharma RP
Pharmacol Toxicol; 1995 Jan; 76(1):17-22. PubMed ID: 7753751
[TBL] [Abstract][Full Text] [Related]
37. Modulation of Retinoic Acid Receptor Subtypes by 5- and 8-Substituted (Naphthalen-2-yl)-based Arotinoids.
Álvarez S; Lieb M; Martínez C; Khanwalkar H; Rodríguez-Barrios F; Álvarez R; Gronemeyer H; de Lera AR
ChemMedChem; 2015 Aug; 10(8):1378-91. PubMed ID: 26012882
[TBL] [Abstract][Full Text] [Related]
38. Relationship between binding affinities to cellular retinoic acid-binding protein and biological potency of a new series of retinoids.
Sani BP; Dawson MI; Hobbs PD; Chan RL; Schiff LJ
Cancer Res; 1984 Jan; 44(1):190-5. PubMed ID: 6317169
[TBL] [Abstract][Full Text] [Related]
39. Identification of retinoids with nuclear receptor subtype-selective activities.
Lehmann JM; Dawson MI; Hobbs PD; Husmann M; Pfahl M
Cancer Res; 1991 Sep; 51(18):4804-9. PubMed ID: 1654201
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of HL-60 differentiation by a new class of retinoids with selective activity on retinoid X receptor.
Apfel CM; Kamber M; Klaus M; Mohr P; Keidel S; LeMotte PK
J Biol Chem; 1995 Dec; 270(51):30765-72. PubMed ID: 8530518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
